Literature DB >> 19647761

Neutralization of Bothrops mattogrossensis snake venom from Bolivia: experimental evaluation of llama and donkey antivenoms produced by caprylic acid precipitation.

Gil Patrick Fernández1, Alvaro Segura, María Herrera, Williams Velasco, Gabriela Solano, José María Gutiérrez, Guillermo León.   

Abstract

Polyspecific bothropic/crotalic and bothropic/lachesic antivenoms were produced in Bolivia by immunizing two donkeys with the venoms of Bothrops mattogrossensis and Crotalus durissus terrificus and one llama with the venoms of B. mattogrossensis and Lachesis muta. These antivenoms are currently being used for snakebite envenomation in Bolivia. The rationale for using these animals is that donkeys and llamas are better adapted than horses to the high altitudes in South America and constitute good alternatives for antivenom production in these regions. Plasma was fractionated by caprylic acid precipitation of non-immunoglobulin plasma proteins, to obtain whole IgG preparations. Donkey-derived antivenom showed one band of 150 kDa when analyzed by SDS-PAGE, whereas llama antivenom presented two immunoglobulin bands, of 170 kDa and 120 kDa, the latter corresponding to the heavy-chain antibodies present in camelid sera. The effectiveness of these antivenoms to neutralize lethal, hemorrhagic, myotoxic, edema-forming, and defibrinogenating activities of the venom of B. mattogrossensis from Bolivia, a species formerly known as Bothrops neuwiedii, was assessed at the experimental level. Although llama antivenom has a total protein concentration four times lower than donkey antivenom, both preparations have similar neutralizing capacity against all toxic activities assessed. Llama and donkey IgG-based antivenoms are effective in the neutralization of B. mattogrossensis venom and represent valuable alternatives for antivenom manufacture in highland regions of South America. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19647761     DOI: 10.1016/j.toxicon.2009.07.031

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  6 in total

1.  Study on camel IgG purification: a new approach to prepare Naja Naja Oxiana antivenom as passive immunization for therapy.

Authors:  Sedigheh Khamehchian; Hossein Zolfagharian; Naser Mohammadpour Dounighi; Majid Tebianian; Rasool Madani
Journal:  Hum Vaccin Immunother       Date:  2014-03-18       Impact factor: 3.452

2.  Landscape of research, production, and regulation in venoms and antivenoms: a bibliometric analysis.

Authors:  José Luis Di Fabio; María de Los Ángeles Cortés Castillo; Elwyn Griffiths
Journal:  Rev Panam Salud Publica       Date:  2021-05-20

3.  Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920).

Authors:  Guilherme H M Salvador; Antoniel A S Gomes; Wendy Bryan-Quirós; Julián Fernández; Matthew R Lewin; José María Gutiérrez; Bruno Lomonte; Marcos R M Fontes
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

4.  In vivo neutralization of α-cobratoxin with high-affinity llama single-domain antibodies (VHHs) and a VHH-Fc antibody.

Authors:  Gabrielle Richard; Ashley J Meyers; Michael D McLean; Mehdi Arbabi-Ghahroudi; Roger MacKenzie; J Christopher Hall
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

5.  Purification and biochemical characterization of three myotoxins from Bothrops mattogrossensis snake venom with toxicity against Leishmania and tumor cells.

Authors:  Andréa A de Moura; Anderson M Kayano; George A Oliveira; Sulamita S Setúbal; João G Ribeiro; Neuza B Barros; Roberto Nicolete; Laura A Moura; Andre L Fuly; Auro Nomizo; Saulo L da Silva; Carla F C Fernandes; Juliana P Zuliani; Rodrigo G Stábeli; Andreimar M Soares; Leonardo A Calderon
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

6.  Donkey-derived anti-CDV IgG, as a passive immunotherapy agent, can effectively increase survival rates of the experimental CDV-infected dogs.

Authors:  Jianlou Zhang; Dan Cui; Yuzhu Zuo; Zhiqiang Zheng; Fengyang Wu; Wenyan Li; Yonghong Zhang; Shanshan Huo; Nan Li; Lanhui Li; Yueqiang Guan; Fei Zhong
Journal:  BMC Vet Res       Date:  2021-08-06       Impact factor: 2.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.